Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-2.38%
1,071.66
-26.15
-2.38%
—1,097.811,087.761,087.761,068.56——
SIXC
Communications
SIXC
Communications
SIXC
-0.69%
607.82
-4.21
-0.69%
—612.03612.03612.03606.60——
SIXE
Energy
SIXE
Energy
SIXE
+1.54%
1,239.20
+18.77
+1.54%
—1,220.431,221.991,240.941,221.99——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.72%
1,729.19
-30.33
-1.72%
—1,759.521,754.311,754.311,726.56——
SIXM
Financials
SIXM
Financials
SIXM
-0.12%
630.80
-0.74
-0.12%
—631.54631.27633.99628.63——
SIXR
Staples
SIXR
Staples
SIXR
-0.15%
855.91
-1.25
-0.15%
—857.16858.91861.71852.33——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-1.25%
212.72
-2.69
-1.25%
—215.41215.41215.41211.92——
SIXT
Technology
SIXT
Technology
SIXT
-1.03%
3,576.78
-37.37
-1.03%
—3,614.153,556.243,577.153,516.86——
SIXU
Utilities
SIXU
Utilities
SIXU
-2.22%
888.13
-20.17
-2.22%
—908.30906.55906.55888.17——
SIXV
Health care
SIXV
Health care
SIXV
-0.85%
1,467.81
-12.59
-0.85%
—1,480.401,479.551,484.431,465.52——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.57%
2,360.82
-37.55
-1.57%
—2,398.372,373.092,373.092,350.27——
ZYME:NASDAQ
Zymeworks Inc
$23.85
-0.46%
(-0.11) 1D
May 15, 1:17:47 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZYME...
Open
$24.50
High
$25.34
Low
$23.66
Mkt. cap
1.74B
Avg. vol.
618.39K
Volume
304.87K
52-wk high
$29.75
52-wk low
$11.02
EPS
-$1.37
Beta
1.20
Shares outstanding
73.02M
No. of employees
243
News stories
From sources across the web
Profile
Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital that year. In May 2017, Zymeworks held an IPO on the Toronto Stock Exchange, raising $59 million. This was the largest Canadian biotech IPO in more than a decade. By alphabetical order, Zymeworks is the last company on the Toronto Stock Exchange. In May 2019, Zymeworks announced that GSK has expanded its 2016 licensing and collaboration agreement for the research, development and commercialization of bispecific antibodies across multiple disease areas. The extended agreement has meant that GSK can have access to Zymeworks' heavy-light chain pairing technology, which enables the development of bispecific and multifunctional therapeutics. Wikipedia
About Zymeworks Inc
CEOKenneth Galbraith
Employees243
Founded2003
HeadquartersMiddletown, Delaware, United States
SectorBiotechnology
Websitezymeworks.com
Last report
May 7, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
-$0.59 / -$0.10
-484.33%miss
Revenue / Est. (USD)
2.41M / 31.95M
-92.46%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
48.73M
27.61M
2.52M
2.41M
Cost of goods sold
34.45M
35.58M
31.24M
34.46M
Cost of revenue
34.45M
35.58M
31.24M
34.46M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.95M
14.15M
15.43M
15.07M
Operating expense
14.95M
14.15M
15.43M
15.07M
Total operating expenses
49.40M
49.72M
46.67M
49.53M
Operating income
-674.00K
-22.11M
-44.15M
-47.12M
Other non operating income
-8.00K
26.00K
-18.00K
120.00K
EBT including unusual items
2.13M
-18.27M
-41.48M
-46.35M
EBT excluding unusual items
2.13M
-18.27M
-41.48M
-46.35M
Income tax expense
-186.00K
1.34M
-270.00K
-2.19M
Effective tax rate
-8.73%
-7.31%
0.65%
4.73%
Other operating expenses
-
-
-
-
Net income
2.32M
-19.60M
-41.21M
-44.16M
Net profit margin
4.76%
-70.99%
-1,638.53%
-1,833.97%
Earnings per share
0.03
-0.26
-0.55
-0.59
Interest and investment income
3.43M
3.53M
2.98M
2.71M
Interest expense
-
-
-
-2.07M
Net interest expenses
3.43M
3.53M
2.98M
645.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
1.82M
-20.56M
-43.07M
-45.98M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer